Biogen Inc.
09/12/2024 | Press release | Distributed by Public on 09/12/2024 05:32
Management Change/Compensation Form 8 K
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(d) Appointment of Dr. Lloyd Minor and Prof Sir Menelas Pangalos to the Board of Directors
On September 11, 2024, the Board of Directors (the "Board") of Biogen Inc. (the "Company") increased the size of the Board and elected Lloyd B. Minor, M.D. and Sir Menelas (Mene) Pangalos, Ph.D. as directors, effective October 1, 2024 and January 1, 2025, respectively, with each director's term expiring at the Company's 2025 Annual Meeting of Stockholders.
Dr. Minor and Prof Sir Pangalos will receive the annual cash and equity compensation received by each of the Company's non-employeedirectors, as described in the Company's proxy statement dated as of April 26, 2024. Both Dr. Minor and Prof Sir Pangalos will enter into an indemnification agreement with the Company on the same terms as the Company has previously entered into with its other directors, a form of which has been previously filed as Exhibit 10.1 to the Company's Current Report on Form 8-Kfiled with the Securities and Exchange Commission on June 7, 2011.
2